Yukiko Hiramatsu
Overview
Explore the profile of Yukiko Hiramatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagao M, Fukuda A, Kashima H, Matsuyama S, Iimori K, Nakayama S, et al.
Eur J Cell Biol
. 2024 Dec;
104(1):151472.
PMID: 39721346
The biliary tract is a ductal network comprising the intrahepatic (IHBDs) and extrahepatic bile duct (EHBDs). Biliary duct disorders include cholangitis, neoplasms, and injury. However, the underlying mechanisms are not...
2.
Okamoto M, Okamura R, Itatani Y, Aisu Y, Kinoshita H, Hoshino N, et al.
Asian J Endosc Surg
. 2024 Aug;
17(4):e13368.
PMID: 39097981
Low-grade appendiceal mucinous neoplasm (LAMN) is principally characterized by low-grade cytology without evidence of invasion to other organs. We report a LAMN surgical case whose appendiceal tumor penetrated the sigmoid...
3.
Hiramatsu Y, Utsumi T, Ikeda M, Seno H
Intern Med
. 2024 Apr;
63(23):3255-3256.
PMID: 38569904
No abstract available.
4.
Omatsu M, Nakanishi Y, Iwane K, Aoyama N, Duran A, Muta Y, et al.
Nat Commun
. 2023 Sep;
14(1):5534.
PMID: 37749092
Mesenchymal activation, characterized by dense stromal infiltration of immune and mesenchymal cells, fuels the aggressiveness of colorectal cancers (CRC), driving progression and metastasis. Targetable molecules in the tumor microenvironment (TME)...
5.
Masuda T, Fukuda A, Yamakawa G, Omatsu M, Namikawa M, Sono M, et al.
J Clin Invest
. 2023 Sep;
133(18).
PMID: 37712427
RECK is downregulated in various human cancers; however, how RECK inactivation affects carcinogenesis remains unclear. We addressed this issue in a pancreatic ductal adenocarcinoma (PDAC) mouse model and found that...
6.
Namikawa M, Fukuda A, Mizukoshi K, Iwane K, Kawai M, Yamakawa G, et al.
J Pathol
. 2023 Jun;
260(4):478-492.
PMID: 37310065
Biliary tract cancer (BTC) has poor prognosis. The Notch receptor is aberrantly expressed in extrahepatic cholangiocarcinoma (eCCA). However, the role of Notch signaling in the initiation and progression of eCCA...
7.
Araki O, Tsuda M, Omatsu M, Namikawa M, Sono M, Fukunaga Y, et al.
Oncogene
. 2023 May;
42(26):2139-2152.
PMID: 37198398
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. We previously reported that chromatin remodeler Brg1 is essential for acinar cell-derived PDAC formation in mice. However, the functional role of Brg1...
8.
Nagao M, Mizukoshi K, Nakayama S, Namikawa M, Hiramatsu Y, Maruno T, et al.
Oncotarget
. 2023 Mar;
14:276-279.
PMID: 36999984
and mutations are frequently observed in extrahepatic biliary cancer. Mutations of and are independent risk factors for poor prognosis in biliary cancer. However, the exact role of p53 in the...
9.
Kumagai K, Shimizu T, Nikaido M, Hirano T, Kakiuchi N, Takeuchi Y, et al.
J Pathol
. 2023 Jan;
259(4):362-368.
PMID: 36625379
Most gastric cancers develop in inflamed gastric mucosa due to Helicobacter pylori infection, typically with metaplastic changes. However, the origins of gastric cancer remain unknown. Here, we present a case...
10.
Yoshikawa T, Fukuda A, Omatsu M, Namikawa M, Sono M, Fukunaga Y, et al.
Cancer Sci
. 2022 Aug;
113(10):3417-3427.
PMID: 35924439
Tumor stem cells (TSCs), capable of self-renewal and continuous production of progeny cells, could be potential therapeutic targets. We have recently reported that chromatin remodeling regulator Brg1 is required for...